Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer.

European urology - 1 Mar 2017

Teply Benjamin A, Kachhap Sushant, Eisenberger Mario A, Denmeade Samuel R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Ataxia Telangiectasia Mutated Proteins
Share to BRCA2 Protein
Share to Frameshift Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation, Missense

Share to Neoplasm Grading

Share to Prostatic Neoplasms, Castration-Resistant

Share to Testosterone

Source

Open in PubMed Open full text

Identifiers

PMID: 27692705
DOI: 10.1016/j.eururo.2016.09.020
PMCID: PMC5808412

Genes

ATM
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer.PMID 27692705Read ↗

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at DeathSemantic proximity Read ↗

Prostate cancer: An abiraterone ultraresponsive phenotype.Semantic proximity Read ↗

Androgen resistance--the clinical and molecular spectrum.Semantic proximity Read ↗

Re: Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study.Semantic proximity Read ↗

Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived XenograftsSemantic proximity Read ↗

Novel hormone therapies for advanced prostate cancer: Understanding and countering drug resistanceSemantic proximity Read ↗

Androgens and prostate cancer.Semantic proximity Read ↗

Mechanisms of androgen-refractory prostate cancer.Semantic proximity Read ↗

Adrenal-Permissive HSD3B1 Genotype-An Invisible Stimulator of Prostate Cancer Mortality.Semantic proximity Read ↗

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanismsSemantic proximity Read ↗

Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survivalSemantic proximity Read ↗

Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivoSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.